Treatment of Lymph Node-Negative, Early-Stage HER2-Positive Breast Cancer

被引:1
|
作者
Oguz, Arzu [1 ]
Keskin, Gul Sema [1 ]
Colak, Dilsen [1 ]
Altundag, Ozden [1 ]
Akcali, Zafer [1 ]
机构
[1] Baskent Univ, Bahcelievler Ankara, Turkey
关键词
ADJUVANT TRASTUZUMAB; RISK; CM;
D O I
10.1200/JCO.2015.63.8411
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:639 / +
页数:3
相关论文
共 50 条
  • [21] Neratinib for the treatment of HER2-positive early stage breast cancer
    Echavarria, Isabel
    Lopez-Tarruella, Sara
    Marquez-Rodas, Ivan
    Jerez, Yolanda
    Martin, Miguel
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (08) : 669 - 679
  • [22] Optimal treatment of early stage HER2-positive breast cancer
    Pernas, Sonia
    Barroso-Sousa, Romualdo
    Tolaney, Sara M.
    [J]. CANCER, 2018, 124 (23) : 4455 - 4466
  • [23] Personalized treatment for early stage HER2-positive breast cancer
    Prat, A.
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [24] Evaluation of the technique of endoscopic axillary sentinel lymph node biopsy in early-stage node-negative breast cancer
    Khallaf, Emad
    Mokhtar, Sherif M.
    Nashat, Engy
    Ali, Mahmoud
    [J]. EGYPTIAN JOURNAL OF SURGERY, 2022, 41 (01): : 247 - 251
  • [25] Clinical Outcomes in Patients with Early Stage Node-Negative HER2-Positive Breast Cancer Receiving Upfront Surgery or Neoadjuvant Systemic Therapy
    Muppidi, Natasha
    Adesoye, Taiwo
    Yi, Min
    Sun, Susie X.
    Chavez-MacGregor, Mariana
    Singh, Puneet
    Karuturi, Meghan
    Tamirisa, Nina
    Hunt, Kelly K.
    Teshome, Mediget
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024,
  • [26] Changing frameworks in treatment sequencing of triple-negative and HER2-positive, early-stage breast cancers
    Pusztai, Lajos
    Foldi, Julia
    Dhawan, Arjun
    DiGiovanna, Michael P.
    Mamounas, Eleftherios P.
    [J]. LANCET ONCOLOGY, 2019, 20 (07): : E390 - E396
  • [27] Real-World Outcomes of Adjuvant Chemotherapy for Node-Negative and Node-Positive HER2-Positive Breast Cancer
    Veitch, Zachary
    Khan, Omar F.
    Tilley, Derek
    Ribnikar, Domek
    Kostaras, Xanthoula
    King, Karen
    Tang, Patricia
    Lupichuk, Sasha
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (01): : 47 - 56
  • [28] Small Tumor Size and Node-Negative HER2-Positive Breast Cancer: A Step Forward for a Better Treatment? Reply
    Curigliano, Giuseppe
    Bagnardi, Vincenzo
    Fumagalli, Luca
    Rotmensz, Nicole
    Locatelli, Marzia
    Viale, Giuseppe
    Goldhirsch, Aron
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : E258 - E259
  • [29] DECRESCENDO: de-escalating chemotherapy in HER2-positive, estrogen receptor-negative, node-negative early breast cancer
    Debien, Veronique
    Adam, Virginie
    Coart, Elisabeth
    Agostinetto, Elisa
    Goulioti, Theodora
    Molinelli, Chiara
    Arahmani, Amal
    Zoppoli, Gabriele
    Piccart, Martine
    [J]. FUTURE ONCOLOGY, 2023, 19 (24) : 1655 - 1667
  • [30] Optimal adjuvant therapy for small node-negative HER2-positive breast cancer in clinical practice
    Osako, T.
    Nishimura, R.
    Nishiyama, Y.
    Okumura, Y.
    Fujisue, M.
    Arima, N.
    [J]. BREAST, 2017, 32 : S25 - S25